Caliber Imaging & Diagnostics Inc
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-… Read more
Market Cap & Net Worth: Caliber Imaging & Diagnostics Inc (LCDX)
Caliber Imaging & Diagnostics Inc (PINK:LCDX) has a market capitalization of $850.74 ($850.74) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51172 globally and #15858 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Caliber Imaging & Diagnostics Inc's stock price $0.00 by its total outstanding shares 8507374 (8.51 Million).
Caliber Imaging & Diagnostics Inc Market Cap History: 2015 to 2025
Caliber Imaging & Diagnostics Inc's market capitalization history from 2015 to 2025. Data shows change from $8.49 Million to $850.74 (-59.33% CAGR).
Caliber Imaging & Diagnostics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Caliber Imaging & Diagnostics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LCDX by Market Capitalization
Companies near Caliber Imaging & Diagnostics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Caliber Imaging & Diagnostics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Caliber Imaging & Diagnostics Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Caliber Imaging & Diagnostics Inc's market cap moved from $8.49 Million to $ 850.74, with a yearly change of -59.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $850.74 | 0.00% |
| 2024 | $850.74 | 0.00% |
| 2023 | $850.74 | -75.00% |
| 2022 | $3.40K | +33.33% |
| 2021 | $2.55K | -99.94% |
| 2020 | $4.08 Million | +6.67% |
| 2019 | $3.83 Million | -65.38% |
| 2018 | $11.06 Million | +54.76% |
| 2017 | $7.15 Million | -47.50% |
| 2016 | $13.61 Million | +60.32% |
| 2015 | $8.49 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Caliber Imaging & Diagnostics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $850.74 USD |
| MoneyControl | $850.74 USD |
| MarketWatch | $850.74 USD |
| marketcap.company | $850.74 USD |
| Reuters | $850.74 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.